info:eu-repo/semantics/article
Development of an experimental hemolytic uremic syndrome in rats
Fecha
2008-04Registro en:
Zotta, Elsa; Lago, Néstor Rubén; Ochoa, Federico Claudio; Repetto, Horacio A.; Ibarra, Cristina Adriana; Development of an experimental hemolytic uremic syndrome in rats; Springer; Pediatric Nephrology; 23; 4; 4-2008; 559-567
0931-041X
CONICET Digital
CONICET
Autor
Zotta, Elsa
Lago, Néstor Rubén
Ochoa, Federico Claudio
Repetto, Horacio A.
Ibarra, Cristina Adriana
Resumen
Escherichia coli strains producing Shiga toxins (Stxs) colonize the lower gastrointestinal tract and cause watery diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome (HUS). HUS is characterized by hemolytic anemia, thrombocytopenia, and acute renal failure. Oliguria associated with acute tubular necrosis and microangiopathic thrombosis has been reported as the most common cause of renal failure in Argentinean children. Our study was undertaken to obtain a model of HUS in rats that was similar to the clinical and renal histopathology findings described in humans. Rats were intraperitoneally inoculated with culture supernatant from recombinant E. coli expressing Stx2. Glomerular filtrate volume evaluated from clearance of creatinine resulted in a progressive reduction (from 53% at 24 h to 90% at 48 h). Urine volume increased significantly at 24 h but returned to normal levels at 48 h. Evidence of thrombocytopenia, anemia and leukocytosis was documented. Macroscopic analysis revealed a hyperemic peritoneal face with intestinal water accumulation. The kidneys were friable and congestive. Histopathological analysis showed glomerular and tubular necrosis as well as microangiopathic thrombosis. Our findings indicated vascular damage and kidney lesions similar to those described in humans with HUS.